Parkinson disease (PD) is a progressive neurodegenerative condition that involves prominent motor dysfunction and nonmotor symptoms consistent with the loss of dopaminergic neurons in the substantia nigra that is attributed to the pathological accumulation of α-synuclein within cells.
1-3 The global impact of PD is increasing as the population ages, with its prevalence more than doubling from 1990 (2.5 million cases) to 2016 (6.1 million cases).
4